AU2002306556A1 - Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms - Google Patents

Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms

Info

Publication number
AU2002306556A1
AU2002306556A1 AU2002306556A AU2002306556A AU2002306556A1 AU 2002306556 A1 AU2002306556 A1 AU 2002306556A1 AU 2002306556 A AU2002306556 A AU 2002306556A AU 2002306556 A AU2002306556 A AU 2002306556A AU 2002306556 A1 AU2002306556 A1 AU 2002306556A1
Authority
AU
Australia
Prior art keywords
isoforms
neurodegenerative diseases
trkc
trkb
novel treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002306556A
Inventor
Linda L Bambrick
Susan G Dorsey
Tami J Kingsbury
Bruce K Krueger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of AU2002306556A1 publication Critical patent/AU2002306556A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2002306556A 2001-02-22 2002-02-22 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms Abandoned AU2002306556A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27055301P 2001-02-22 2001-02-22
US60/270,553 2001-02-22
PCT/US2002/005151 WO2002067858A2 (en) 2001-02-22 2002-02-22 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms

Publications (1)

Publication Number Publication Date
AU2002306556A1 true AU2002306556A1 (en) 2002-09-12

Family

ID=23031768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002306556A Abandoned AU2002306556A1 (en) 2001-02-22 2002-02-22 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms

Country Status (2)

Country Link
AU (1) AU2002306556A1 (en)
WO (1) WO2002067858A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060030534A1 (en) * 2002-09-04 2006-02-09 Gabriele Dorn Treatment of neurological disorders by dsrna administration
CA2690685A1 (en) * 2007-06-20 2008-12-24 Galapagos N.V. Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
ES2479815B1 (en) * 2012-12-24 2015-05-06 Consejo Superior De Investigaciones Cientificas (Csic) NEUROPROTECTOR PEPTIDE ASI AS ITS USE IN THE TREATMENT OF CEREBROVASCULAR DISEASES AND OTHER CNS PATHOLOGIES

Also Published As

Publication number Publication date
WO2002067858A3 (en) 2003-02-27
WO2002067858A2 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU3173301A (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU2003904328A0 (en) Diagnosis and treatment of neurodegenerative disorders
AU2002257333A1 (en) Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
EP1455780A4 (en) Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
AU2002228652A1 (en) Treatment of disorders using polyethylenimine diazeniumdiolate
AU2002306556A1 (en) Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms
ATE443060T1 (en) BENZOAQUINOLINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA AND MIOPSIGHTEDNESS
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
GB0100092D0 (en) Treatment of degenerative diseases
AU2002365654A1 (en) Treatment of diseases via the skin
AUPR819901A0 (en) Treatment of plants
AU2002330085A1 (en) Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
AU2002233329A1 (en) GABA-receptor modulators for the treatment of neurodegenerative diseases of the eye
AUPR916701A0 (en) Composition for the treatment of infectious and/or skin diseases
AU2002302805A1 (en) Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents
AU2002247685A1 (en) Tripeptide derivatives for the treatment of neurodegenerative diseases
AU2002362599A1 (en) Treatment of allergic rhinitis
AUPR894001A0 (en) Treatment of Oocytes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase